Nephrocare Health Services Limited (BOM:544647)
India · Delayed Price · Currency is INR 573.95
-1.80 (-0.31%)
At close: Feb 13, 2026
BOM:544647 Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 670.96 | 351.33 | -117.89 | -219.75 | 10.02 |
Depreciation & Amortization | 719.18 | 540.19 | 465.16 | 389.03 | 316.74 |
Other Amortization | 5.51 | 8.66 | 3.63 | 3.69 | 6 |
Loss (Gain) From Sale of Assets | - | 0.65 | - | - | - |
Asset Writedown & Restructuring Costs | 4.26 | 12.28 | - | 27.68 | 15.6 |
Loss (Gain) From Sale of Investments | -7.55 | - | - | - | - |
Stock-Based Compensation | 63.8 | 18.64 | 20.87 | 5.4 | 27.96 |
Provision & Write-off of Bad Debts | 88.57 | 114.89 | 66.68 | 83.28 | 36.42 |
Other Operating Activities | 250.47 | 6.18 | 207.48 | -5.45 | 162.3 |
Change in Accounts Receivable | -667.31 | -505.6 | -543.04 | -234.48 | -74.45 |
Change in Inventory | 0.67 | 9.7 | -108.38 | 16.99 | -13.73 |
Change in Accounts Payable | 398.71 | 183.68 | 135.45 | 11.48 | -44.61 |
Change in Other Net Operating Assets | -173.8 | -17.8 | -17.27 | 41.31 | -116.73 |
Operating Cash Flow | 1,353 | 722.8 | 112.69 | 119.18 | 325.51 |
Operating Cash Flow Growth | 87.25% | 541.41% | -5.45% | -63.39% | - |
Capital Expenditures | -997.75 | -773.49 | -715.69 | -429.7 | -505.42 |
Cash Acquisitions | -125.41 | -281.37 | -64.17 | -626.82 | -474.69 |
Sale (Purchase) of Intangibles | -10.22 | -26.52 | -21.69 | -3.51 | -3.33 |
Investment in Securities | 47.27 | 459.66 | -46.03 | -642.23 | 294.43 |
Other Investing Activities | -164.62 | 115.12 | 65.52 | 27.38 | 47.46 |
Investing Cash Flow | -1,251 | -506.6 | -782.06 | -1,675 | -641.55 |
Short-Term Debt Issued | 81.05 | 13.73 | 620.78 | - | 326.35 |
Long-Term Debt Issued | - | 723.68 | 388.61 | 184.03 | 184 |
Total Debt Issued | 81.05 | 737.41 | 1,009 | 184.03 | 510.35 |
Short-Term Debt Repaid | - | - | - | -189.9 | - |
Long-Term Debt Repaid | -328.91 | -310.52 | -238.81 | -224.65 | -90.83 |
Total Debt Repaid | -328.91 | -310.52 | -238.81 | -414.55 | -90.83 |
Net Debt Issued (Repaid) | -247.86 | 426.89 | 770.58 | -230.53 | 419.51 |
Issuance of Common Stock | 979.65 | 5.58 | 23.63 | 1,811 | 10.37 |
Other Financing Activities | -188.08 | -165.08 | -194.55 | -111.98 | -71.85 |
Financing Cash Flow | 543.71 | 267.39 | 599.66 | 1,474 | 358.04 |
Foreign Exchange Rate Adjustments | 0.21 | -12.68 | 24.8 | - | - |
Net Cash Flow | 646.66 | 470.91 | -44.91 | -81.95 | 42.01 |
Free Cash Flow | 355.72 | -50.69 | -603 | -310.52 | -179.91 |
Free Cash Flow Margin | 4.71% | -0.90% | -13.79% | -9.80% | -6.32% |
Free Cash Flow Per Share | 4.25 | -0.63 | -7.83 | -37.45 | -7.74 |
Cash Interest Paid | 188.1 | 165.08 | 161.13 | 96.66 | 72.38 |
Cash Income Tax Paid | 9.57 | 80.63 | -46.21 | 47.94 | -133.36 |
Levered Free Cash Flow | 110.99 | 20.41 | -1,417 | -279.76 | - |
Unlevered Free Cash Flow | 228.91 | 139.16 | -1,326 | -219.18 | - |
Change in Working Capital | -441.73 | -330.02 | -533.24 | -164.7 | -249.52 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.